Form EFFECT - Notice of Effectiveness

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form EFFECT - Notice of Effectiveness

Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Ventyx Biosciences Charts.

Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Ventyx Biosciences Charts.

Ventyx Biosciences Inc News

Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Wednesday 5 February 2025 (1 day ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 14 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio
Tuesday 14 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 3 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 30 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

More Ventyx Biosciences Inc News Articles

Vontobel Financial Produ...

XS2723536467 20271229 62...

Vontobel Financial Produ...

Vontobel Financial Produ...

WisdomTree Commodity Sec...

BNP Paribas Issuance

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions